Caribou Biosciences (CRBU) Change in Acquisitions & Divestments (2022 - 2026)

Caribou Biosciences (CRBU) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $46.1 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 30.04% year-over-year to $46.1 million in Q1 2026; TTM through Mar 2026 was $233.0 million, a 36.4% decrease from a year earlier, with the FY2025 full-year figure at $252.8 million, down 36.39% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $46.1 million, down from $61.8 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for CRBU reached as high as $120.7 million in Q3 2024 and fell as low as $39.3 million in Q1 2022.
• Historically, Change in Acquisitions & Divestments has averaged $75.7 million across 5 years, with a median of $68.4 million in 2025.
• Across the five-year window, Change in Acquisitions & Divestments surged 151.06% in 2023 and tumbled 47.43% in 2025, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $89.7 million in 2022, then plunged by 38.72% to $55.0 million in 2023, then surged by 30.81% to $71.9 million in 2024, then fell by 14.11% to $61.8 million in 2025, then retreated by 25.32% to $46.1 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $46.1 million in Q1 2026, $61.8 million in Q4 2025, and $68.4 million in Q3 2025.